• About INIA-Neuroimmune
  • Resources
  • Publications
  • Meetings
  • News
  • Contact Us
  • Skip to primary navigation
  • Skip to main content
UT Shield
Integrative Neuroscience Initiative on Alcoholism
  • About INIA-Neuroimmune
    • INIA-N Research Projects
    • INIA-N Organizational Structure
  • Resources
    • Mutant animals in alcohol research
    • Knock-in mice and alcohol publications
  • Publications
  • Meetings
    • Past Meetings
  • News
  • Contact Us
The University of Texas at Austin

January 22, 2025, Filed Under: 2023, Publication

Pre-clinical and clinical evidence forsuppression of alcohol intake by apremilast.

Citation:

Grigsby KB, Mangieri RA, Roberts AJ, Lopez MF, Firsick EJ, Townsley KG, Beneze A, Bess J, Eisenstein TK, Meissler JJ, Light JM, Miller J, Quello S, Shadan F, Skinner MH, Aziz HC, Metten P, Morissett RA, Crabbe JC, Roberto M, Becker HC, Mason BJ, and Ozburn AR. “Pre-clinical and clinical evidence forsuppression of alcohol intake by apremilast..” The Journal of clinical investigation, 133, 6, Pp. e159103. Publisher’s Version

Last updated on 06/01/2023

UT Home | Emergency Information | Site Policies | Web Accessibility | Web Privacy | Adobe Reader

© The University of Texas at Austin 2025